Terrestrial Bio

Terrestrial is a biotechnology company dedicated to unlocking the therapeutic potential of the "dark matter" within the microbial world. By leveraging advanced genomic sequencing and synthetic biology, the company identifies and characterizes novel natural products from soil-dwelling organisms that have historically been difficult to culture. Their platform focuses on biosynthetic gene clusters (BGCs) to discover next-generation small molecule therapeutics for challenging diseases in oncology and immunology. Terrestrial aims to revitalize natural product drug discovery through a high-throughput, data-driven approach that bypasses traditional cultivation limitations. The company is headquartered in San Francisco and is backed by prominent life science and technology investors.